Active Ingredient: HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
Proprietary Name: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A088025
Product Number: 001
Approval Date: Nov 23, 1984
Applicant Holder Full Name: ASCOT HOSP PHARMACEUTICALS INC DIV TRAVENOL LABORATORIES INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
